Us Congress House Bill HB3382

Us Congress 2023-2024 Regular Session

• Introduced: 5/16/23
• Refer: 5/16/23
• Refer: 5/19/23

Caption

Colorectal Cancer Payment Fairness Act

Impact

If enacted, HB3382 would have a significant impact on Medicare beneficiaries, as it removes the co-payment aspect for certain colorectal screenings. This change is anticipated to enhance early detection rates of colorectal cancer, potentially saving lives through timely intervention. The legislation shifts the financial responsibility from patients to the Medicare program, which could lead to increased utilization of screening services, ultimately aiming to reduce the incidence of advanced cancer cases through preventive care.

Summary

House Bill 3382, known as the Colorectal Cancer Payment Fairness Act, seeks to amend the Social Security Act to eliminate the coinsurance requirement for certain colorectal cancer screening tests covered under the Medicare program. By removing this financial barrier, the bill aims to increase access to vital screening services for colorectal cancer, which is one of the leading causes of cancer-related deaths. The legislation underscores a commitment to preventive healthcare and is designed to encourage individuals to undergo necessary screenings without the concern of additional costs.

Contention

Discussions around HB3382 may reflect broader debates concerning healthcare affordability and the role of government in reducing costs for patients. While supporters, including various healthcare advocacy groups, argue that the elimination of coinsurance for screenings is a positive step towards improved public health outcomes, some critics might voice concerns about the financial impact on Medicare funding. Additionally, the potential for increased demand on screening resources could spark discussions about healthcare capacity and resource allocation.